These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Possibilities of thermal medicine in gastrointestinal functional disorders]. Grassi M; Lucchetta MC; Grossi F; Raffa S Clin Ter; 2002; 153(3):195-206. PubMed ID: 12161982 [TBL] [Abstract][Full Text] [Related]
5. New therapies for functional bowel diseases. Coulie B; Camilleri M Curr Gastroenterol Rep; 2000 Oct; 2(5):355-63. PubMed ID: 10998662 [TBL] [Abstract][Full Text] [Related]
6. [Functional and motor gastrointestinal disorders]. Mearin F; Rey E; Balboa A Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():3-12. PubMed ID: 26520191 [TBL] [Abstract][Full Text] [Related]
7. "Kapping" visceral pain in patients with irritable bowel syndrome: does it work? Pasricha PJ Gastroenterology; 1996 Aug; 111(2):531-3. PubMed ID: 8690223 [No Abstract] [Full Text] [Related]
8. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Mönnikes H; Tebbe JJ; Hildebrandt M; Arck P; Osmanoglou E; Rose M; Klapp B; Wiedenmann B; Heymann-Mönnikes I Dig Dis; 2001; 19(3):201-11. PubMed ID: 11752838 [TBL] [Abstract][Full Text] [Related]
9. [Functional colonic diseases: from physiopathology to pharmacology]. Bardou M Rev Med Interne; 1999 Feb; 20(2):151-7. PubMed ID: 10227093 [TBL] [Abstract][Full Text] [Related]
10. New developments in the treatment of functional dyspepsia. Stanghellini V; De Ponti F; De Giorgio R; Barbara G; Tosetti C; Corinaldesi R Drugs; 2003; 63(9):869-92. PubMed ID: 12678573 [TBL] [Abstract][Full Text] [Related]
12. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives]. Delvaux M; Frexinos J Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379 [No Abstract] [Full Text] [Related]
13. [Electrogastrography monitoring of the effectiveness of prokinetic and cognitive therapy in functional dyspepsia]. Fodor G; Schwab R; Gyökeres T; Pap A Orv Hetil; 2005 Jun; 146(26):1393-7. PubMed ID: 16052981 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology and clinical experience with fedotozine. Delvaux M Expert Opin Investig Drugs; 2001 Jan; 10(1):97-110. PubMed ID: 11116283 [TBL] [Abstract][Full Text] [Related]
16. The influence of cisapride on gastric tone and the perception of gastric distension. Tack J; Broeckaert D; Coulie B; Janssens J Aliment Pharmacol Ther; 1998 Aug; 12(8):761-6. PubMed ID: 9726390 [TBL] [Abstract][Full Text] [Related]
17. Functional bowel disease: roles of sensation and motility. Camilleri M Schweiz Med Wochenschr; 2000 Nov; 130(46):1772-81. PubMed ID: 11127957 [TBL] [Abstract][Full Text] [Related]
18. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Koloski NA; Talley NJ; Huskic SS; Boyce PM Aliment Pharmacol Ther; 2003 Mar; 17(6):841-51. PubMed ID: 12641507 [TBL] [Abstract][Full Text] [Related]
19. [Management of gastroparesis and functional dyspepsia after cisapride withdrawal]. Louis H Rev Med Brux; 2012 Sep; 33(4):425-9. PubMed ID: 23091951 [TBL] [Abstract][Full Text] [Related]
20. Hypnotherapy for functional gastrointestinal disorders: a review. Miller V; Whorwell PJ Int J Clin Exp Hypn; 2009 Jul; 57(3):279-92. PubMed ID: 19459089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]